Edmund V Capparelli

5PUBLICATIONS
51CO-AUTHORS
Nanotoxicology, health and safetyMedical infection agents (incl. prions)NeonatologyInnate immunity
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|May 06, 2026
VRC01 with antiretroviral initiation in infants is well tolerated, and higher concentrations associate with greater HIV-1 DNA declines.

|Apr 20, 2026
Population pharmacokinetics and safety of continuous oxacillin in preterm and term neonates and infants.

|Feb 20, 2025
Single Doses of Pediatric Dolutegravir Dispersible Tablets in Neonates Support Multidosing: PETITE-Dolutegravir Study.

Tim R Cressey, Nicolas Salvadori, Helena Rabie

|Jul 05, 2023
Broadly neutralizing antibody treatment maintained HIV suppression in children with favorable reservoir characteristics in Botswana.

Roger L Shapiro, Gbolahan Ajibola, Kenneth Maswabi

|Jan 25, 2018
Safety and pharmacokinetics of the Fc-modified HIV-1 human monoclonal antibody VRC01LS: A Phase 1 open-label clinical trial in healthy adults.

Martin R Gaudinski, Emily E Coates, Katherine V Houser

Pageof 1

Frequent Collaborators

2 joint publications

Dwight E Yin

2 joint publications

Lucio Gama

2 joint publications

Adrian McDermott

1 joint publications

Elizabeth J McFarland